KRRO - NASDAQ

Korro Bio, Inc.

KRRO·NASDAQ

$11.08

+2.1%

HealthcareBiotechnology

Korro Bio, Inc., a biopharmaceutical company, discovers, develops, and commercializes genetic medicines based on editing RNA for the treatment of rare and highly prevalent diseases. Korro Bio, Inc. is based in Cambridge, Massachusetts.

Statements Value Model

At a Glance

Live Snapshot

Market Cap$110.28M

EPS-12.4800

P/E Ratio-0.89

Earnings Date08/11/2026

krro

Total Current Assets

Last Annual Value

82.37M

3-Year CAGR

13%

5-Year CAGR

-18%

10-Year CAGR

16%

Adjust for Inflation

Korro Bio, Inc. Competitors Analysis of Total Current Assets

KRRO · NASDAQ

Company	Total Current Assets	CAGR 3Y	CAGR 5Y	CAGR 10Y
Korro Bio, Inc. NASDAQ:KRRO	82.37M	-21.9%	-9.4%	N/A
Alto Neuroscience, Inc. NYSE:ANRO	177.72M	27.7%	45.0%	N/A
Aura Biosciences, Inc. NASDAQ:AURA	149.74M	-13.6%	-0.5%	N/A
Larimar Therapeutics, Inc. NASDAQ:LRMR	142.02M	16.3%	14.5%	0.8%
Altimmune, Inc. NASDAQ:ALT	278.19M	9.9%	6.4%	2.3%
MBX Biosciences, Inc. Common Stock NASDAQ:MBX	381.54M	66.0%	N/A	N/A
Quantum-Si incorporated NASDAQ:QSI	175.86M	-12.9%	-18.1%	N/A
RAPT Therapeutics, Inc. NASDAQ:RAPT	235.24M	13.3%	4.0%	N/A
Rocket Pharmaceuticals, Inc. NASDAQ:RCKT	192.73M	-20.1%	-13.2%	4.1%
LB Pharmaceuticals Inc Common Stock NASDAQ:LBRX	308.43M	89.1%	N/A	N/A
Annexon, Inc. NASDAQ:ANNX	242.19M	-2.8%	-0.4%	N/A

Korro Bio, Inc. Fair Value Envelope

KRRO · NASDAQ

Our analysis suggests that KRRO has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $11.08, this represents a potential HIDDEN relative to our calculated worth for Korro Bio, Inc..

HIDDEN

Intrinsic Value

Current Price: $11.08

Related Guides

Blog Categories

Continue your KRRO research with focused valuation guides.

Fundamentals

Decode statement quality and operating durability.

Accounting

Interpret line items with cleaner analytical framing.

Forecasting

Translate historical performance into forward scenarios.

Reference

Use practical frameworks for statement-led valuation.

Research Paths

Pick your next lens

Snapshot

Start with context, operating signals, and key market metrics.

Value Model

Stress test fair value across bear, base, and bull assumptions.

Statements

Validate revenue quality, margins, and balance sheet durability.

Earnings Call

Read management commentary and compare it with reported outcomes.

Dividends

Check payout sustainability and long-term distribution behavior.

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.